Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;102:864-865
doi: 10.1161/CIRCRESAHA.108.175562
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caglayan, E.
Right arrow Articles by Rosenkranz, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caglayan, E.
Right arrow Articles by Rosenkranz, S.
Related Collections
Right arrowRelated Article
(Circulation Research. 2008;102:864.)
© 2008 American Heart Association, Inc.


Editorials

Living on the Edge

Hypoxia-Induced Tissue Damage

Evren Caglayan, Stephan Rosenkranz

From the Klinik III für Innere Medizin, and Center for Molecular Medicine Cologne, Universität zu Köln, Germany.

Correspondence to Evren Caglayan, MD, Klinik III für Innere Medizin, Universität zu Köln, Kerpener Str. 62, D-50937 Köln, Germany. E-mail evren.caglayan@uk-koeln.de



See related article, pages 905–913


Key Words: AGE • hypoxia • RAGE • egr-1


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

How a seemingly simple signal (ie, hypoxia) becomes transduced into biochemical and molecular responses that mediate maladaptive tissue damage is the defining enigma in various events that lead to oxygen deprivation, such as myocardial infarction, stroke, and venous thromboembolism. It is well established that acute hypoxia leads to numerous cellular events, such as formation of reactive oxygen species and induction of hypoxia-inducible factor-1.1 Furthermore, the immediate early gene, early growth response (Egr)-1, appears as an integral component of the biological response to hypoxia,2 because its upregulation induces the expression of fundamental inflammatory and prothrombotic stress genes.3 Nevertheless, the exact role of the above molecules and the link between hypoxia and Egr-1 upregulation/inflammation remains elusive. It is certainly desirable to better characterize the molecular basis of hypoxic cellular injury to develop pathway-specific therapeutic strategies to limit hypoxia-induced tissue damage in various organs such as the heart, brain, and vasculature.

Formation of advanced glycation end products (AGEs) are implicated in the pathogenesis of diabetic micro- and macrovascular complications, resulting in diabetic heart disease, accelerated atherosclerosis, end-stage renal failure, a variety of neuropathies, and acquired blindness.4 For several years, it has been known that high blood glucose concentrations promote AGE formation inside and outside cells.5 In addition, there is increasing evidence that AGE formation also occurs independent of plasma glucose levels. For example, oxidants generated by the NADPH oxidase of neutrophils, monocytes, and macrophages may also play a role in AGE formation in vivo by a glucose-independent pathway.6

The interaction of glucose-modified and . . . [Full Text of this Article]


Related Article:

Oxygen Deprivation Triggers Upregulation of Early Growth Response-1 by the Receptor for Advanced Glycation End Products
Jong Sun Chang, Thoralf Wendt, Wu Qu, Linghua Kong, Yu Shan Zou, Ann Marie Schmidt, and Shi-Fang Yan
Circ. Res. 2008 102: 905-913. [Abstract] [Full Text] [PDF]